Skip to content

A Clinical study to evaluate the effect of Tuvaraka rasayana kalpa in type-2 diabetes mellitus

A clinical study to evaluate the effect of tuvaraka rasayana kalpa on increased blood glucose level in type-2 diabetes mellitus - nil

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074655
Enrollment
30
Registered
2024-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Dr Ashrita
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.HbA1c more than 6.5 percentage 2.FBS 126mg/dL-300mg/dL 3.PPBS more than 200mg/dL 4. Willing to give informed consent

Exclusion criteria

Exclusion criteria: 1. Patients under anti-hyperglycemic drugs 2. Any systemic disorder which will interfere with present tratment 3. Patients associated with complications like Diabetic Neuropathy, Diabetic Nephropathy, Diabetic Retinopathy, Ischemic Heart Disease, Gestational Diabetes

Design outcomes

Primary

MeasureTime frame
Changes in FBS and PPBSTimepoint: 25 days

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Ashrita

Sri Dharmasthala Manjunatheshwara College of Ayurveda Hospital and Research Center Kuthpady Udupi

yogeeshadr@gmail.com9886055775

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026